Cap-dependent endonuclease-IN-13_product_DataBase

CAS: 2703046-60-8 F: C25H20F2N4O4S W: 510.51

Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-I

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-13 has the potential for the research of influenza virus infection (only influenza A) (extracted from patent WO2021180147A1, compound I-1)[1].
Name	Cap-dependent endonuclease-IN-13
CAS	2703046-60-8
Formula	C25H20F2N4O4S
Molar Mass	510.51
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Zhen Xu, et al. An influenza virus inhibitor. Patent WO2021180147A1.

PeptideDB